Microbiology of Cystic Fibrosis Airway Disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Although survival of individuals with cystic fibrosis (CF) has been continuously improving for the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains the leading cause of mortality in this patient population. Certain pathogens such as Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and species of the Burkholderia cepacia complex continue to be associated with poorer clinical outcomes including accelerated lung function decline and increased mortality. In addition, other organisms such as anaerobes, viruses, and fungi are increasingly recognized as potential contributors to disease progression. Culture-independent molecular methods are also being used for diagnostic purposes and to examine the interaction of microorganisms in the CF airway. Given the importance of CF airway infections, ongoing initiatives to promote understanding of the epidemiology, clinical course, and treatment options for these infections are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & ABPA complicating asthma ISHAM working group (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12141 · Cited by 896 · cited 1×
“ABPA is characterized by asthma-like symptoms, a positive Aspergillus skin test and an elevated serum IgE. 145 Episodes of ABPA can lead to decline in pulmonary function and are typically treated with systemic steroids.”
Background(2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00579-09 · Cited by 804
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599 · cited 1×
“156, 160 Overall, these findings suggest that the microbiome of CF airways changes across ages and disease stages.”
BackgroundInflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
Zemanick, E. T., Harris, J. K., Wagner, B. D., Robertson, C. E., Sagel, S. D., Stevens, M. J., Accurso, F. J., & Laguna, T. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062917 · Cited by 180 · cited 1×
“[110] [111] [112] [113] [114] [115]”
Impact of Burkholderia Infection on Lung Transplantation in Cystic Fibrosis
Murray, S., Charbeneau, J., Marshall, B. C., & LiPuma, J. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1834oc · Cited by 177 · cited 1×
“62, 63 In addition, B. cenocepacia, 42,64 as well as other species such as B. multivorans, 65 has been linked to cepacia syndrome, a clinical entity characterized by necrotizing pneumonia and sepsis with near-total fatality rates.”
BackgroundEffects of upper respiratory tract infections in patients with cystic fibrosis.
Collinson, J., Nicholson, K. G., Cancio, E., Ashman, J., Ireland, D. C., Hammersley, V, Kent, J., & O'Callaghan, C. (1996) · Thorax · doi:10.1136/thx.51.11.1115 · Cited by 173 · cited 1×
“120, 121, [123] [124] [125] Viral infections are detected more frequently in children than in adults with CF. 126 In addition, children with CF are more likely to experience significant morbidity associated with viral infections compared with children without CF. 117, 123, 127, 128 The increased severity of viral infe…”
BackgroundHendricks, M. R., Lashua, L. P., Fischer, D. K., Flitter, B. A., Eichinger, K. M., Durbin, J. E., Sarkar, S. N., Coyne, C. B., Empey, K. M., & Bomberger, J. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516979113 · Cited by 168
Stephenson, A. L., Sykes, J., Berthiaume, Y., Singer, L. G., Aaron, S. D., Whitmore, G. A., & Stanojevic, S. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.05.003 · Cited by 102 · cited 1×
“62, 63 In addition, B. cenocepacia, 42,64 as well as other species such as B. multivorans, 65 has been linked to cepacia syndrome, a clinical entity characterized by necrotizing pneumonia and sepsis with near-total fatality rates.”
Background
Cited by
Ethnobotany and the Role of Plant Natural Products in Antibiotic Drug Discovery
Porras, G., Chassagne, F., Lyles, J. T., Marquez, L., Dettweiler, M., Salam, A. M., Samarakoon, T., Shabih, S., Farrokhi, D. R., & Quave, C. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00922 · Cited by 378
Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies
Vidaillac, C., & Chotirmall, S. H. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1906225 · Cited by 87
Metadata
- Authors
- Blanchard, A. C., & Waters, V. J.
- Venue
- Seminars in Respiratory and Critical Care Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2019-12
- Volume
- 40
- Issue
- 06
- Pages
- 727-736
- ISSN
- 1069-3424 (ISSN-L)
- 1098-9048
- OpenAlex
- W2998341485
- Cited by
- 167
- References
- 11
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.